Pharmacogenetically tailored treatments for heart disease

Related Experiment Video

Updated: Jun 13, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Elizabeth Vafiadaki1, Demetrios A Arvanitis, Evangelia G Kranias

  • 1Molecular Biology Division, Biomedical Research Foundation, Academy of Athens, Soranou Efesiou 4, 115 27 Athens, Greece.

Current Pharmaceutical Design
|May 13, 2010
PubMed

Insights

Genetic variations impact heart disease drug effectiveness and toxicity. Pharmacogenetics offers personalized treatment strategies, improving patient outcomes and guiding new drug development for better cardiac care.

Area of Science:

  • Cardiology
  • Pharmacogenetics

Background:

  • Heart disease is a leading global cause of death, with current treatments showing variable patient responses.
  • Existing therapies manage heart function, rhythm, blood pressure, cholesterol, and clotting, but individual efficacy differs.
  • Genetic variations influence how patients metabolize and respond to cardiac medications, affecting treatment success.

Purpose of the Study:

  • To explore the impact of genetic polymorphisms on patient response to heart disease drugs.
  • To highlight the role of pharmacogenetics in optimizing cardiac pharmacotherapy.
  • To discuss the potential for personalized medicine in treating heart disease.

Main Methods:

  • Review of existing literature on genetic polymorphisms and cardiovascular drug response.
  • Analysis of pharmacokinetic and pharmacodynamic variations due to genetic factors.
  • Examination of adverse drug reactions linked to genetic profiles.

Main Results:

  • Genetic polymorphisms significantly affect drug absorption, distribution, metabolism, and excretion (ADME) in cardiac patients.
  • Variations in drug response and toxicity are linked to specific gene polymorphisms.
  • Pharmacogenetics provides insights into inter-individual variability in treatment efficacy.

Conclusions:

  • Pharmacogenetics is crucial for tailoring heart disease drug selection and dosage to individual patients.
  • Understanding genetic influences can minimize adverse drug reactions and maximize therapeutic benefits.
  • Personalized, targeted therapies hold promise for future cardiovascular care, improving patient outcomes.

More Related Videos

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans08:21

Intradermal Microdialysis: An Approach to Investigating Novel Mechanisms of Microvascular Dysfunction in Humans

Published on: July 21, 2023

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...